(1)
Together the companies will increase radiological report automation through AI and Anatomical Mapping and will create unparalleled longitudinal data
Brainlab, a digital medical technology company, announced today the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image reading and reporting software for clinical routine and research. The acquisition underscores the Brainlab commitment to digital health and aims to improve the structured diagnosis, analysis and treatment of cancer and other diseases to address the demands of modern medicine and personalized treatments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210310005267/en/ The transformation of our health care system is currently focused in large part on standardizing clinical data through a coding system, commented Stefan Vilsmeier, President and CEO, Brainlab. However, high quality and consistency of such data requires a va
Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination With Avelumab Versus Avelumab Monotherapy in Patients With HPV16-positive Anogenital Cancers
-
Trial will focus on patients without liver metastases, based on encouraging data in Phase Ib/II study
-
Trial targets indications where clinical outcomes can be improved versus standard therapeutic options and immune checkpoint inhibitors ( ICIs )
-
Continued clinical collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to conduct the expanded Phase II study
Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces the expansion of a randomized, controlled study with TG4001 in combination with avelumab versus avelumab monotherapy in patients with HPV16-positive anogenital tumors (NCT: 03260023)
Ammunition Market Size to Reach USD 28.81 Billion in 2027 | Rising Emphasis on Self Defense Among Civilians And Increasing Investment in Arms and Ammunition are Major Factors Driving Industry Growth, says Emergen Research Key players in the Ammunition market Smith & Wesson Holding Corp., Freedom Group, Orbital ATK, Sturm, Ruger, & Co., Inc., American Outdoor Brand Corporation, Thales Group, Lockheed Martin, General Dynamics Corporation, Beretta S.p.A., and Raytheon Company, among others.
March 10, 2021 15:00 ET | Source: Emergen Research Emergen Research Surrey, CANADA
Vancouver, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) The global ammunition market size is expected to reach USD 28.81 Billion in 2027 and register a moderate CAGR during the forecast period, according to latest analysis by Emergen Research. Some key factors influencing market growth include increasing adoption of arms and ammunition for s